Carbamic acid, N-[(3S,4R)-4-(3,4-dichlorophenyl)-1-[[1-[(1-methylcyclopropyl)carbonyl]-4-piperidinyl]carbonyl]-3-pyrrolidinyl]-N-methyl-, 4-fluorophenyl ester

Carbamic acid, N-[(3S,4R)-4-(3,4-dichlorophenyl)-1-[[1-[(1-methylcyclopropyl)carbonyl]-4-piperidinyl]carbonyl]-3-pyrrolidinyl]-N-methyl-, 4-fluorophenyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

• Beschreibung

  RO-5328673 is a dual NK2/NK3 antagonist. O5328673. [(3)H]RO5328673 bound to a single saturable site on hNK2, hNK3 and gpNK3 with high-affinity. RO5328673 acted as an insurmountable antagonist at both human and guinea-pig NK3 receptors in the [(3)H]IP accumulation assay. In binding kinetic analyses, [(3)H]RO5328673 had fast association and dissociation rates at hNK2 while it had a fast association rate and a remarkably slow dissociation rate at gp and hNK3. In electrophysiological recordings of gp SNpc, RO5328673 inhibited the senktide-induced potentiation of spontaneous activity of dopaminergic neurons with an insurmountable mechanism of action. RO5328673 exhibited in-vivo activity in gerbils, robustly reversing the senktide-induced locomotor activity.

Carbamic acid, N-[(3S,4R)-4-(3,4-dichlorophenyl)-1-[[1-[(1-methylcyclopropyl)carbonyl]-4-piperidinyl]carbonyl]-3-pyrrolidinyl]-N-methyl-, 4-fluorophenyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(1)Suppliers